The average melanoma-to-kidney ratios for 111In-labeled 3-arm DOTA-α-MSH were 0.07, 0.10, 0.21, 0.40, and 0.50 at 10, 30, 60, 120, and 180 min after injection, respectively. This evidence concerns the gene STAMBP and melanoma.